Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.76
Delayed Data
As of Jun 20
 -0.03 / -1.68%
Today’s Change
0.93
Today|||52-Week Range
3.75
-13.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.006.0M0.000.00
 
 
Depreciation And Amortization692.0K261.0K70.0K63.0K
 
 
 
 
 
 
Operating ExpensesGross Income-692.0K---70.0K-63.0K
 
 
 
 
General Expenses9.4M13.6M8.0M9.5M
 
 
 
 
 
Research And Development3.9M9.3M3.6M5.9M
 
 
 
 
 
Total Operating Expenses10.1M13.8M8.0M9.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.1M-7.8M-8.0M-9.5M
 
 
 
 
 
Extraordinary Charge-6.9M0.000.000.00
 
 
Interest Expense On Debt300.0K287.0K121.0K93.0K
 
 
 
 
 
Other Expenses18.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.0M-7.1M-8.0M-9.5M
 
 
 
 
 
Income Taxes0.000.00-720.0K0.00
 
 
Net Income-17.0M-7.1M-7.3M-9.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.5M50.6M50.7M51.9M
 
 
 
 
 
Shares To Calculate EPS Diluted50.5M50.6M50.7M51.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.14-$0.14-$0.18
 
 
 
 
 
EPS Diluted-$0.34-$0.14-$0.14-$0.18